Variable | BMI <25 kg/m2 (n=853) | BMI ≥25 kg/m2 (n=593) | Variable | BMI <25 kg/m2 | BMI ≥25 kg/m2 |
---|---|---|---|---|---|
Age, years (mean ± SD) | 32.4±12.5 | 38.8±13.8 | Fasting glucose≥5.6 mmol/L, n (%) | 134/772 (17.3) | 126/519 (24.2)* |
SLE duration, weeks (mean ± SD) | 22.9±17.9 | 25.5±17.8 | Smokers, n (%) | 115/851 (13.5) | 101/590 (17) |
Mets diagnosis, n (%) | 193/853 (22.6) | 242/591 (40.9)* | Low physical activity§, n (%) | 279/768 (36.4) | 149/389 (38.5) |
Systolic BP, mmHg | 115 (105–125) | 120 (112–132)* | SLEDAI | 4 (2–8) | 4 (1–8) |
Diastolic BP, mmHg | 70 (68–80) | 80 (70–84)* | SLICC/ACR–DI | 0 (0–0) | 0 (0–0) |
Total cholesterol, mmol/L | 4.52 (3.8–5.6) | 4.88 (4.0–5.7) | Anti-dsDNA positive, n (%) | 343/771 (44.5) | 176/531 (33.2)* |
Triglycerides, mmol/L | 1.47 (0.9–2.2) | 1.45 (1.0–2.2) | Low complement, n (%) | 669/853 (78.4) | 451/591 (76.1) |
HDL, mmol/L | 1.25 (0.9–1.17) | 1.3 (1.1–1.7) | Average CS daily dose, mg | 12.5 (0–30) | 10 (0–25) |
Fasting glucose, mmol/L | 4.71 (4.3–5.2) | 4.82 (4.3–5.4) | Immunosuppressant use, n (%) | 359/852 (42.1) | 222/591 (37.5) |
Data expressed as median (IQR) unless otherwise indicated. BP blood pressure; CS, corticosteroids; HDL, high density lipoprotein; MetS, metabolic syndrome. §Low physical activity was defined as less than one hour/day of moderate-to-intense job or less than 30 minutes/day of moderate activity during leisure time; *p<0.05 at univariate analysis.